Modulators of androgen synthesis
AssigneeTangent Reprofiling Limited
InventorsSuzanne Dilly, Gregory Stoloff, Paul Taylor
Life of this patent
Estimating the term…
Abstract
The present specification discloses compositions comprising at least one therapeutic compound capable of modulating androgen production and methods and uses for treating a disorder associated with androgen production using such compositions and/or compounds.
Claims20
A method of treating an individual with a prostate cancer, the method comprising the step of administering to the individual a therapeutically effective amount of risperidone and from 0.01 mg/kg/day to 0.5 mg/kg/day of a 9Z,11E conjugated Linoleic Acid, wherein administration reduces a symptom associated with the prostate cancer, thereby treating the individual,
- wherein there is a synergistic effect between the risperidone and the 9Z,11E conjugated Linoleic Acid.
A method of treating an individual with a prostate cancer, the method comprising the step of administering to the individual from 0.01 mg/kg/day to 0.5 mg/kg/day of a risperidone and from 0.01 mg/kg/day to 0.5 mg/kg/day of a 9Z,11E conjugated Linoleic Acid, wherein administration reduces a symptom associated with the prostate cancer, thereby treating the individual,
- wherein there is a synergistic effect between the risperidone and the 9Z,11E conjugated Linoleic Acid.
A method of treating an individual with a prostate cancer, the method comprising the step of administering to the individual a therapeutically effective amount of risperidone and from 0.1 mg/day to 20 mg/day of a 9Z,11E conjugated Linoleic Acid, wherein administration reduces a symptom associated with the prostate cancer, thereby treating the individual,
- wherein there is a synergistic effect between the risperidone and the 9Z,11E conjugated Linoleic Acid.
A method of treating an individual with a prostate cancer, the method comprising the step of administering to the individual from 0.1 mg/day to 20 mg/day of a risperidone and from 1 mg/day to 20 mg/day of a 9Z,11E conjugated Linoleic Acid, wherein administration reduces a symptom associated with the prostate cancer, thereby treating the individual,
- wherein there is a synergistic effect between the risperidone and the 9Z,11E conjugated Linoleic Acid.
Dependencies are inferred from the claim text.